Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
ContributorsDurier, Christine; Ninove, Laetitia; Lefebvre, Maeva; Radenne, Anne; Desaint, Corinne; Ropers, Jacques ; Bauer, Rebecca; Lebbah, Said; Carette, Diane; Lachatre, Marie; Lecompte, Anne-Sophie; Deplanque, Dominique ; Botelho-Nevers, Elisabeth; Conrad, Anne; Dussol, Bertrand; Maakaroun-Vermesse, Zoha; Melica, Giovanna; Nicolas, Jean-François; Verdon, Renaud; Kiladjian, Jacques; Loubet, Paul ; Schmidt-Mutter, Catherine; Dualé, Christian; Ansart, Séverine; Priet, Stéphane; Levier, Axel; Molino, Diana; Vieillard, Louis-Victorien; Parfait, Béatrice; Lelièvre, Jean-Daniel; Tartour, Eric; de Lamballerie, Xavier; Launay, Odile; ANRS0002S CoviCompareP Group; AP-HP CoviCompareM Group
CollaboratorsEberhardt, Christiane Sigrid; Siegrist, Claire-Anne
Published inScientific reports, vol. 12, no. 1, 20373
Publication date2022-11-27
First online date2022-11-27
Abstract
Keywords
- Humans
- Aged
- Aged, 80 and over
- Antibodies, Neutralizing
- SARS-CoV-2 / genetics
- Neutralization Tests
- Antibodies, Viral
- RNA, Messenger
- Viral Vaccines
- COVID-19 / prevention & control
- Vaccination
Affiliation entities
Research groups
Citation (ISO format)
DURIER, Christine et al. Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years. In: Scientific reports, 2022, vol. 12, n° 1, p. 20373. doi: 10.1038/s41598-022-24409-w
Main files (1)
Article (Published version)
Identifiers
- PID : unige:173792
- DOI : 10.1038/s41598-022-24409-w
- PMID : 36437298
- PMCID : PMC9701678
ISSN of the journal2045-2322